- 专利标题： Amorphous form of linagliptin and process for preparation thereof
-
申请号： US14384567申请日： 2013-03-12
-
公开(公告)号： US09879011B2公开(公告)日： 2018-01-30
- 发明人: Shriprakash Dhar Dwivedi , Ashok Prasad , Kuldeep Natwarlal Jain , Kumar Kamlesh Singh , Jitendra Maganbhai Gajera
- 申请人： CADILA HEALTHCARE LIMITED
- 申请人地址： IN Ahmedabad
- 专利权人： Cadila Healthcare Limited
- 当前专利权人： Cadila Healthcare Limited
- 当前专利权人地址： IN Ahmedabad
- 代理机构： Ladas & Parry LLP
- 优先权： IN653/MUM/2012 20120312
- 国际申请： PCT/IN2013/000148 WO 20130312
- 国际公布： WO2013/171756 WO 20131121
- 主分类号： C07D473/04
- IPC分类号： C07D473/04 ; C07D473/06
摘要：
The present invention relates to an amorphous form of linagliptin and processes for the preparation thereof. The invention also relates to a pharmaceutical composition comprising a therapeutically effective amount of an amorphous form of linagliptin and use of the composition for treatment of diabetes especially type-I or type-II, prediabetes or reduction of glucose tolerance.
公开/授权文献
信息查询
